CV logo

CAPSOVISION INC

CVNASDAQ
πŸ† #3112 by market capUS Equity
$7.09β€”
Last available close Β· quote unavailable
πŸ””
Track CV
Get earnings, price moves & breaking news on Telegram
Track
24hβ€”
7dβ–² 4.6%
14dβ–² 9.8%
30dβ–² 5.7%
ytdβ–Ό 32.7%
1yβ–² 49.3%
🏦Market Cap
$359M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-22.2%
Declining
πŸ“ŠGross Margin
50.9%
Healthy
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
26.4x
Expensive
Otter Score
56
Fair

Trading Snapshot

Day Range
β€”
52-Week Range
$4.50 – $15.37
Volume (shares)
β€”
Avg Volume (shares)
β€”
Shares Outstanding
53.2M
Next Earnings
β€”

Fundamentals Snapshot

Annual Revenue
$14M
Last Q Revenue
$4M
P/E Ratio
β€”
P/S Ratio
26.4x
EPS (TTM)
$-0.63
Dividend Yield
β€”
Dilution (1yr)
+1.1%
CV logo

CAPSOVISION INC

CV
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$14Mβ–² +15.3% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
52.9%β–Ό βˆ’2.4% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$26Mβ–² +28.1% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$23Mβ–² +13.4% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
46.9Mβ–² +1.1% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$9Mβ–² +$1M YoY
StockOtter Β· stockotter.space

About CAPSOVISION INC

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
56/100
Analyst data unavailable.

Latest News & Updates

News unavailable.